Bioaminex does not sell products directly. Everything begins with lab work and a licensed physician. Please confirm you understand:
Peptide therapies may involve compounds that are prescription-only or investigational. Nothing here should be used without physician supervision and appropriate laboratory monitoring.
An anxiolytic peptide approved over-the-counter in Russia — with a human evidence base that hasn't been independently replicated in the West.
Selank is a good example of a compound that's a real, approved drug — just not here, and not tested the way US regulators require. Here's the honest breakdown.
Selank was developed at the Russian Academy of Medical Sciences and is approved over-the-counter in Russia and several CIS countries as an anxiolytic (anti-anxiety) nasal spray. It is not FDA-approved in the US, and most Selank available in the US is sold labeled "for research use only" rather than for human administration.
Selank appears to modulate GABA-A receptor activity, increase brain-derived neurotrophic factor (BDNF) expression, and slow the breakdown of enkephalins (natural opioid-like peptides) — a mechanism distinct from benzodiazepines, without their sedation or dependence profile in the studies conducted so far.
The most-cited human study compared roughly 30 Selank patients to 32 patients on medazepam (a benzodiazepine) for generalized anxiety and neurasthenia, reporting anxiolytic effects without sedation. That's real human data — and it's also a small trial, published in a Russian-language journal, using methodology that predates modern Western trial standards, without independent replication outside Russia. Worth taking seriously as a research signal; not equivalent to a Western Phase 3 trial.
Reported human use suggests a favorable side-effect profile compared to benzodiazepines — notably without the sedation, dependence, or withdrawal concerns of that drug class. Given the limited independent replication, a full modern safety profile isn't established the way it would be for a Western-approved anxiolytic, which is a reason for provider oversight rather than self-directed use.
Selank has real approval and real human trial data — just from a regulatory and research tradition that hasn't been independently verified in the West. That's a meaningfully different situation than a compound with no human data at all, but it's still not the same as US clinical evidence, and should be framed that way.
Regulatory status as of 2026-07-20.
This article is for educational purposes only and is not medical advice. It does not establish a provider-patient relationship. FDA-approval status and clinical information are summarized in general terms and may change; consult a licensed healthcare provider and current prescribing information before making any medical decision. Bioaminex does not sell or dispense Selank or any medication.